ITRM vs SRPT · rev $390.0K vs rev $1.90B
Iterum Therapeutics PLC (ITRM) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ITRM currently screens at market cap $38.6M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ITRM and SRPT stock pages for the full models.
Not investment advice.